Article (Scientific journals)
Percutaneous left atrial appendage closure: procedural techniques and outcomes.
Saw, Jacqueline; LEMPEREUR, Mathieu
2014In JACC. Cardiovascular Interventions, 7 (11), p. 1205-20
Peer Reviewed verified by ORBi
 

Files


Full Text
JACC Intv-Saw-2014-LAA review.pdf
Publisher postprint (3.66 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Atrial Appendage/physiopathology; Atrial Fibrillation/complications/diagnosis/physiopathology/therapy; Cardiac Catheterization/adverse effects/instrumentation/methods; Equipment Design; Hemorrhage/etiology; Humans; Risk Assessment; Risk Factors; Stroke/etiology/prevention & control; Time Factors; Treatment Outcome; Amplatzer Cardiac Plug; Amulet; Lariat; WATCHMAN; left atrial appendage closure
Abstract :
[en] Percutaneous left atrial appendage closure technology for stroke prevention in patients with atrial fibrillation has significantly advanced in the past 2 decades. Several devices are under clinical investigation, and a few have already received Conformite Europeene (CE)-mark approval and are available in many countries. The WATCHMAN device (Boston Scientific, Natick, Massachusetts) has the most supportive data and is under evaluation by the U.S. Food and Drug Administration for warfarin-eligible patients. The Amplatzer Cardiac Plug (St. Jude Medical, Plymouth, Minnesota) has a large real-world experience over the past 5 years, and a randomized trial comparing Amplatzer Cardiac Plug with the WATCHMAN device is anticipated in the near future. The Lariat procedure (SentreHEART Inc., Redwood City, California) has also gained interest lately, but early studies were concerning for high rates of serious pericardial effusion and major bleeding. The current real-world experience predominantly involves patients who are not long-term anticoagulation candidates or who are perceived to have high bleeding risks. This pattern of practice is expected to change when the U.S. Food and Drug Administration approves the WATCHMAN device for warfarin-eligible patients. This paper reviews in depth the procedural techniques, safety, and outcomes of the current leading devices.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Saw, Jacqueline
LEMPEREUR, Mathieu ;  Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Cardiologie interventionnelle
Language :
English
Title :
Percutaneous left atrial appendage closure: procedural techniques and outcomes.
Publication date :
2014
Journal title :
JACC. Cardiovascular Interventions
ISSN :
1936-8798
eISSN :
1876-7605
Publisher :
Elsevier, Netherlands
Volume :
7
Issue :
11
Pages :
1205-20
Peer reviewed :
Peer Reviewed verified by ORBi
Commentary :
Copyright (c) 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Available on ORBi :
since 17 August 2018

Statistics


Number of views
37 (2 by ULiège)
Number of downloads
1 (1 by ULiège)

Scopus citations®
 
132
Scopus citations®
without self-citations
112
OpenCitations
 
116

Bibliography


Similar publications



Contact ORBi